Evidence map›Paper›PMID 19779355›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2010

Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda.

Carolyne Onyango-Makumbi, Danstan Bagenda, Antony Mwatha, Saad B Omer, Philippa Musoke, Francis Mmiro, Sheryl L Zwerski, Brenda Asiimwe Kateera, Maria Musisi, Mary Glenn Fowler and 2 more

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Mortality risk and associated factors in HIV-exposed, uninfected children.Tropical medicine & international health : TM & IH · 2016
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Infant feeding practices among HIV-positive mothers at Tembisa hospital, South Africa.African journal of primary health care & family medicine · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carolyne Onyango-MakumbiMakerere University–Johns Hopkins University Research Collaboration/MU-JHU CARE LTD, Kampala, Uganda. carolonyango@mujhu.org
Danstan Bagenda
Antony Mwatha
Saad B Omer
Philippa Musoke
Francis Mmiro
Sheryl L Zwerski
Brenda Asiimwe Kateera
Maria Musisi
Mary Glenn Fowler
J Brooks Jackson
Laura A Guay

Funding

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) GroupU01AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI JACKSON, J BROOKS · 2006 to 2010
$109.7M
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials NetworkU01AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DONNELL, DEBORAH J · 2006 to 2010
$28.8M
Makerere Univ.-Johns Hopkins Univ. HIV Clinical Trials Unit-Kampala, UgandaU01AI069530 · NIAID · JOHNS HOPKINS UNIVERSITY · PI FOWLER, MARY GLENN · 2007 to 2011
$25.8M
ZDV USE TO PREVENT MATERNAL/INFANT HIV TRANSMISSIONU01AI038576 · NIAID · JOHNS HOPKINS UNIVERSITY · PI RUFF, ANDREA JENAY · 2005 to 2007
$15.3M
MU-JHU HPTU TRIAL SITE--UGANDAU01AI048054 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GUAY, LAURA A · 2000 to 2006
$14.4M
Retargeting of Retroviral VectorsR01AI069350 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHEN, IRVIN S.Y. · 2006 to 2010
$1.7M
HIV-IG FOR PREVENTION OF VERTICAL TRANSMISSIONR01AI034235 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACKSON, JAY B · 1993 to 2003
$1.5M
STATISTICAL &CLINICAL COORDINATING CENTER (SC)N01AI045200 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SELF, STEVEN G. · 1994 to 2000
$853k
INTNL.VACC.EFFICACY TRIALS MASTER CONTRACT (IMC)N01AI035173 · NIAID · FAMILY HEALTH INTERNATIONAL · PI CATES, WILLARD · 1993 to 2000
$0k
NIAID NIH HHS N01 AI035173NIAID NIH HHS N01 AI045200NIAID NIH HHS N01-AI-35173- 417NIAID NIH HHS R01 AI034235NIAID NIH HHS R01 AI069350NIAID NIH HHS R01-AI34235NIAID NIH HHS U01 AI038576NIAID NIH HHS U01 AI048054NIAID NIH HHS U01 AI068617NIAID NIH HHS U01 AI068632NIAID NIH HHS U01 AI069530NIAID NIH HHS UO1 AI038576NIAID NIH HHS UO1 AI048054NIAID NIH HHS UO1 AI068617NIAID NIH HHS UO1 AI69530
6 · The paper itself

Abstract

Objective: To assess serious gastroenteritis risk and mortality associated with early cessation of breastfeeding in infants enrolled in 2 prevention of maternal-to-child HIV-transmission trials in Uganda.Methods: We used hazard rates to evaluate serious gastroenteritis events by month of age and mortality among HIV-exposed uninfected infants enrolled in the HIV Network for Prevention Trials (HIVNET 012) (1997–2001) and HIV hyperimmune globulin (HIVIGLOB)/nevirapine (NVP) (2004–2007) trials. HIV-infected mothers were counseled using local infant feeding guidelines current at the time.Results: Breastfeeding cessation occurred earlier in HIVIGLOB/NVP compared with HIVNET 012 (median 4.0 versus 9.3 months,P,0.001). Rates of serious gastroenteritis were higher in HIVIGLOB/NVP (8.0/1000 child-months) than in HIVNET 012 (3.1/1000 child-months; P , 0.001). Serious gastroenteritis events also peaked earlier at 3–4 and 7–8 months (16.2/1000 and 15.0/1000 child-months,respectively) compared with HIVNET 012 at 9–10 months (20.8/1000 child-months). All cause infant mortality did not statistically differ between the HIVIGLOB/NVP and the HIVNET 012 trials [3.2/1000 versus 2.0/1000 child-months, respectively (P = 0.10)].Conclusions: Early breastfeeding cessation seen in the HIVIGLOB/NVP trial was associated with increased risk of serious gastroenteritis among HIV-exposed uninfected infants when compared with later breastfeeding cessation in the HIVNET 012 trial.Testing interventions, which could decrease HIV transmission through breastfeeding and allow safe

Indexed as

Prenatal Exposure Delayed EffectsWeaningAdultBreast FeedingFemaleGastroenteritisHIV InfectionsHumansInfantInfant, NewbornInfant, Newborn, DiseasesInfectious Disease Transmission, VerticalMaleMother-Child RelationsPregnancyTime Factors

Identifiers

PMID19779355
PMCPMC2888913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.